Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPRIT: Telmisartan in Hypertension with Renal Impairment
NCT02178306Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2000
- Primary completion
- Apr 2002
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Sep 2000; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02178306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178306.